Patents Examined by Audrea B Coniglio
  • Patent number: 10675237
    Abstract: The present invention relates to a cosmetic comprising an acrylonitrile-butadiene rubber (NBR) as a carrier of a cosmetic composition and, specifically, to a cosmetic comprising a foam carrier and a cosmetic composition loaded on the foam carrier, wherein the foam carrier contains an NBR, includes pores with an average size of 200-900 ?m, and has a thickness of 1-50 mm, and wherein the cosmetic composition has a viscosity of 2,000-60,000 cps. The present invention has excellent filling ability, loading ability, and discharging ability with respect to the liquid-phase cosmetic composition, and thus facilitates carrying a liquid-phase cosmetic composition with low viscosity to high viscosity.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: June 9, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Jung Sun Choi, Kyung Ho Choi
  • Patent number: 10653718
    Abstract: The invention relates to a specific composition for oral administration of magnesium, for use in the treatment of type 2 diabetes or the complications thereof, in association with a composition for treating type 2 diabetes or the complications thereof.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: May 19, 2020
    Inventor: Fabienne Joanny Menvielle-Bourg
  • Patent number: 10631616
    Abstract: A sheet pack comprising an absorbent layer impregnated with a treatment composition containing at least one ingredient that when topically applied to skin stimulates a gene that is variably expressed over a 24 hour period in native untreated skin cells; the sheet pack contained in a package with user instructions to topically apply the sheet pack to the skin at a time when the gene that is stimulated by the ingredient is being maximally expressed in native untreated skin cells; and methods for treating skin and methods for making a sheet pack.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: April 28, 2020
    Assignee: ELC Management LLC
    Inventors: Anne Carullo, Jennifer Palmer Quintano, Joyce Kassouf, Nadine Pernodet, Donald Collins, Dawn Layman, Allan Hafkin, Osvaldo Fontanet
  • Patent number: 10610480
    Abstract: A personal care conditioning, color protecting and/or styling composition for a keratin substrate comprising: (A) at least one conditioning and/or styling ter/tetra polymer obtained from polymerizing: (i) about 0.1 wt. % to 99 wt. % of acrylamidopropyl trimethylammonium chloride (APTAC), a cationic monomer; (ii) about 0.1 wt. % to 30 wt. % of at least one anionic monomer selected from the group consisting of (a) acrylic acid (AA), (b) acrylamido methylpropyl sulfonate (AMPS), and/or (c) sodium methyl allyl sulfonate (SMAS); and (iii) about 0.1 wt. % to about 20 wt. % of methacryloylaminopropyl lauryl-dimethyl ammonium chloride (MAPLDMAC), a hydrophobically modified cationic monomer; (B) at least one cosmetically acceptable excipient; and (C) optionally, at least one effective amount of personal care active ingredient.
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: April 7, 2020
    Assignee: ISP Investments LLC
    Inventors: Amna Khatun, Michael Franzke, Lidia Kulcsar, Gijsbert Kroon, Linda C. Foltis
  • Patent number: 10596092
    Abstract: The present invention relates to a composition and a deodorizing preparation comprising such composition for reducing, inhibiting or suppressing malodour developed from a body part of a subject. The composition comprises an active ingredient in an effective amount, the active ingredient comprising one or more of a hexamine, a derivative thereof and a compound thereof. The composition further comprises a buffer system adapted to maintain pH of the composition within a range of about 7.0 to about 11.0 when the composition is applied on the body part. The buffer system is adapted to substantially neutralise topical acidity of the body part to thereby reduce or minimise generation of skin-irritating formaldehyde from the hexamine comprising active ingredient.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: March 24, 2020
    Inventor: Chung Hing Lao
  • Patent number: 10583102
    Abstract: The present invention relates to the field of Wilson Disease. More specifically, the present invention provides methods and compositions useful for treating Wilson Disease by targeting liver nuclear receptors. In a specific embodiment, a method for treating Wilson Disease in a subject comprises the step of administering to the subject an effective amount of a liver X receptor (LXR) agonist.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: March 10, 2020
    Assignee: The Johns Hopkins University
    Inventors: Svetlana Lutsenko, James Hamilton
  • Patent number: 10576024
    Abstract: A makeup cosmetic composition contains a first composite powder and a second composite powder, wherein the first composite powder and the second composite powder are plate-like powders coated in a coating layer. The first composite powder contains a coating layer having an average thickness of 20 to 70 nm, and the second composite powder contains a coating layer having an average thickness of 74 to 104 nm.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: March 3, 2020
    Assignee: Amorepacific Corporation
    Inventor: Se Jun Park
  • Patent number: 10577554
    Abstract: Provided herein are various gas-filled particles having a stabilized membrane that encapsulates the gas. Pharmaceutical compositions, methods of use and treatment, and methods of preparation are also described.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 3, 2020
    Assignee: Children's Medical Center Corporation
    Inventors: John Kheir, Brian D. Polizzotti
  • Patent number: 10575519
    Abstract: Wipes for preventing quaternary ammonium (“quat”) depletion suitable for commercial applications (e.g., industrial and consumer disinfectant wipes) are provided. The wipe includes at least one nonwoven layer, at least one pulp layer, and a cationic additive. The at least one nonwoven layer and the at least one pulp layer may be hydroentangled to form a hydroentangled nonwoven fabric having a first surface and a second surface. Additionally, the cationic additive may be disposed on at least one of the first surface or the second surface.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: March 3, 2020
    Assignee: AVINTIV Specialty Materials Inc.
    Inventors: Herbert P. Hartgrove, Dianne B. Ellis, Dawn Ellen Huston, Teresa Ann Oldham
  • Patent number: 10561672
    Abstract: The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: February 18, 2020
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Ulhas R. Dhuppad, Ashok Katkurwar, Yashwant Gupta, Rajesh Ankam, Chandrakant Dhatrak
  • Patent number: 10537526
    Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: January 21, 2020
    Assignee: Purdue Pharma L.P.
    Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
  • Patent number: 10537528
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine or cystamine compositions. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: January 21, 2020
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Patrice Rioux
  • Patent number: 10525002
    Abstract: A compound, composition, and method for the protection of skin from the harmful effects of radiation, and particularly the harmful effects of high energy visible (HEV) radiation, are disclosed. The compound is a melanin derivative that can be formulated into compositions containing the melanin derivative and a suitable carrier. The composition is topically applied to the skin to reduce the risk of photoaging and improve skin repair due to damage from radiation.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: January 7, 2020
    Inventors: James Gallas, Nava Dayan
  • Patent number: 10517984
    Abstract: An antimicrobial suture comprising a filament and taurolidine.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: December 31, 2019
    Assignee: CorMedix Inc.
    Inventors: Robert DiLuccio, Z. Paul Lorenc, Randy Milby
  • Patent number: 10517880
    Abstract: The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: December 31, 2019
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Ulhas R. Dhuppad, Ashok Katkurwar, Yashwant Gupta, Rajesh Ankam, Chandrakant Dhatrak
  • Patent number: 10517879
    Abstract: The present invention includes an apparatus and method for aiding mood, emotion, or physiological state comprising: a substrate that is capable of capturing or absorbing one or more organic compounds from a subject having a first physiologic or emotional state at a first time; and an element that is capable of controlling the capture of the one or more organic compounds at a first time, or the release of the one or more organic compounds from the substrate at a second time, wherein exposure to an effective amount of the organic compounds changes the mood, emotion, or physiological state of the subject.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: December 31, 2019
    Assignee: Performance Labs PTE. LTD.
    Inventor: Daniel Gubler
  • Patent number: 10507197
    Abstract: Disclosed is a pharmaceutical composition containing silibinin, which is prepared from the following bulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, and 25-200 parts of Pu'er tea extract. The drug has the function of treating non-alcoholic fatty liver.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: December 17, 2019
    Assignee: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: Naifeng Wu, Xijun Yan, He Sun, Kaijing Yan, Yonghong Zhu, Shunnan Zhang, Xiaolin Bai, Yi He, Xiaohui Ma, Ting Li, Lei Li
  • Patent number: 10500304
    Abstract: Embodiments of the present disclosure are directed to perforated polymer films and methods of making the same. In some embodiments, the films are for use with implantable medical devices. In one embodiment there is a flexible body including a polymer film having a first surface and an opposing second surface, the film having a plurality of apertures extending from the first surface to the second surface and a plurality of raised lips protruding from the first surface such that each of the plurality of apertures is surrounded by a one of the plurality of raised lips. In one embodiment, the film comprises a single layer, and in another embodiment, the film can comprise a plurality of layers. In certain embodiments, the film can comprise an adhesive layer. In another embodiment, one or more of the layers may be a drug containing layer and/or a rate controlling layer for drug release.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: December 10, 2019
    Assignee: DePuy Synthes Products, Inc.
    Inventors: David A. Armbruster, James Dwyer, Jeffrey Chomyn, Sean H. Kerr
  • Patent number: 10470983
    Abstract: Provided is a beauty care pack including: a support; a shape retaining layer that is laminated on the support so as to be separated from the support by moisture and is formed by electrospinning a polymer material, to maintain moisturizing and hold the shape of the beauty care pack; and a chemical liquid layer that is laminated on the shape retaining layer and is formed by electrospinning a water-soluble polymer material and a functional material, and that is a dry type and melted by moisture, to thus be easily and conveniently stored and packaged, and conveniently used since the dry sheet is attached on the face of a user.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: November 12, 2019
    Assignee: AMOLIFESCIENCE CO., LTD.
    Inventors: In Yong Seo, Ji Hyun Lee
  • Patent number: 10471181
    Abstract: The presently disclosed composition and methods are provided for a hydrogel or nanofiber-hydrogel composite integrated with a surgical scaffold or mesh. A surgical scaffold device comprised of laminar composite is disclosed for the purpose of reducing foreign body response, managing tissue-materials interface, and improving the integration of the surgical mesh with the surrounding tissue of a subject.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: November 12, 2019
    Assignee: The Johns Hopkins University
    Inventors: Russell Martin, Sashank Reddy, Justin Sacks, Xiaowei Li, Brian Honewee Cho, Hai-quan Mao